Bachem Holding AG is a Swiss biotechnology company active in the fields of chemistry, biochemistry and pharmaceuticals. It specializes in the development and manufacturing of peptides, oligonucleotides, and complex organic compounds as active pharmaceutical ingredients, as well as peptide-based biochemicals and related manufacturing processes. Founded in 1971 and headquartered in Bubendorf, in the canton of Basel-Landschaft, Bachem has developed into one of the leading global suppliers of peptide-based APIs. The company is listed on the SIX Swiss Exchange under the ticker symbol BANB and has been publicly traded since 1998. Bachem operates production sites in Switzerland, the United States and the United Kingdom, as well as a sales and distribution office in Japan. At the end of 2025, the company employed 2,511 full-time equivalents. In 2025, it reported revenue of CHF 695.1 million, operating income of CHF 167.3 million, and net income of CHF 148.8 million, reflecting continued growth and strong profitability. Wikipedia